Determinants of quinolone resistance in Escherichia coli causing community-acquired urinary tract infection in Bejaia, Algeria
Open Access
- 1 June 2014
- journal article
- research article
- Published by Medknow in Asian Pacific Journal of Tropical Medicine
- Vol. 7 (6) , 462-467
Abstract
Objective: To investigate the mechanisms of quinolone resistance and the association with other resistance markers among Esherichia coli(E. coli) strains isolated from outpatient with urinary tract infection in north of Algeria. Methods: A total of 30 nalidixic acid resistant E. coli isolates from outpatient with urinary tract infections from January 2010 to April 2011 in north of Algeria (Bejaia) were studied. Antimicrobial susceptibility was determined by disc diffusion assay, minimal inhibitory concentrations (MIC) of quinolone were determined by microdilution. Mutations in the Quinolone Resistance-Determining Region (QRDR) of gyrA and parC genes and screening for qnr (A, B and S) and bla genes were done by PCR and DNA sequencing. Results: Most of the E. coli isolates (56.66%) were shown to carry mutations in gyrA and parC (gyrA: Ser83Leu + Asp87Asn and parC:Ser80Ile). While, 16.66% had only an alteration in g)tA: Ser83Leu. One isolate produced qnrB like and two qnrS-like. Four isolates were CTX-M-15 producers associated with TEM-1 producing in one case. Co-expression of bla(crx-m-15) and qnrB was determined in one E. coli isolate. Conclusions: Our findings suggested the community emergence of gyrA and parC alterations and QnrB determinants that contributed to the development and spread of fluoroquinolone resistance in Algerian E. coli isolates.Keywords
This publication has 32 references indexed in Scilit:
- Outbreak of multidrug-resistant Klebsiella pneumoniae carrying qnrB1 and bla in a French intensive care unitAnnals of Intensive Care, 2013
- In Vitro Effect of qnrA1 , qnrB1 , and qnrS1 Genes on Fluoroquinolone Activity against Isogenic Escherichia coli Isolates with Mutations in gyrA and parCAntimicrobial Agents and Chemotherapy, 2011
- Plasmid-Mediated Quinolone Resistance: a Multifaceted ThreatClinical Microbiology Reviews, 2009
- New Plasmid-Mediated Quinolone Resistance Gene, qnrC , Found in a Clinical Isolate of Proteus mirabilisAntimicrobial Agents and Chemotherapy, 2009
- Antibiotic Resistance in Urinary Isolates of Escherichia coli from College Women with Urinary Tract InfectionsAntimicrobial Agents and Chemotherapy, 2009
- qnrD , a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human OriginAntimicrobial Agents and Chemotherapy, 2009
- Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2009
- New Plasmid-Mediated Fluoroquinolone Efflux Pump, QepA, Found in an Escherichia coli Clinical IsolateAntimicrobial Agents and Chemotherapy, 2007
- Mutant Prevention Concentrations of Fluoroquinolones for Enterobacteriaceae Expressing the Plasmid-Carried Quinolone Resistance Determinant qnrA1Antimicrobial Agents and Chemotherapy, 2007
- qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United StatesAntimicrobial Agents and Chemotherapy, 2006